TET2 and pulmonary arterial hypertension: Here, using blood from our published cohorts of control subjects, patients with PAH and no mutation, and patients with PAH and a documented TET2 mutation (Potus et al. 2020), we identify a global hypermethylation signature in patients with PAH.